האיחוד האירופי - פינית - EMA (European Medicines Agency)

eisai gmbh - bexaroteenin - lymfooma, t-solu, iho - antineoplastiset aineet - targretin-kapselit on tarkoitettu hoidettaessa kehittyneitä vaiheita ihon t-solulymfooma (ctcl) -potilaita, jotka ovat tulenkestäviä ainakin yhdelle systeemiselle hoidolle.

האיחוד האירופי - פינית - EMA (European Medicines Agency)

ge healthcare as - mangafodipir trinatriumia - magneettikuvaus - kontrastimediat - tämä lääkevalmiste on tarkoitettu vain diagnostiseen käyttöön. varjoaineen diagnostiikka magneettikuvaus (mri) havaitsemiseksi vaurioita maksan epäillään johtuvan metastasoitunut tauti tai hepatosellulaariset karsinoomat. lisänä mri tukea tutkimuksen polttoväli haiman vaurioita.

האיחוד האירופי - פינית - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - sian sirkoviruksen tyypin 2 orf2-proteiini - immunologiset suidaeille - siat - aktiivinen immunisointi siat, joilla ei ole pcv2 emolle saatujen vasta-iästä alkaen 2 viikkoa vastaan sian sirkovirus tyyppi 2 (pcv2),.

האיחוד האירופי - פינית - EMA (European Medicines Agency)

dr. falk pharma gmbh - budesonide - ruokatorven taudit - ripulilääkkeet, suoliston antiinflammatory / antiinfective agents - jorveza on tarkoitettu kohtelu eosinofiilinen ruokatorvitulehdus (eoe) aikuiset (yli 18 vuotta).

האיחוד האירופי - פינית - EMA (European Medicines Agency)

bayer animal health gmbh - iron(iii) ion, toltrazuril - toltratsuriili, yhdistelmiä - siat (porsaat) - sillä samanaikainen ehkäisy kokkidioosin kliinisten oireiden (kuten ripuli) vastasyntyneiden porsaiden maatiloilla, joilla on vahvistettu historia kokkidioosin aiheuttamaa cystoisospora suis, ja ehkäisyyn raudanpuute anemia.

האיחוד האירופי - פינית - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - rokotteet - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. käyttö tämä rokote tulee virallisten suositusten mukaisesti.

האיחוד האירופי - פינית - EMA (European Medicines Agency)

orion corporation - pregabaliini - epilepsialääkkeet - kissat - alleviation of acute anxiety and fear associated with transportation and veterinary visits.

האיחוד האירופי - פינית - EMA (European Medicines Agency)

sun pharmaceutical industries (europe) b.v. - ertapeneeminatrium - bakteeri-infektiot - ertapenem - treatmentertapenem sun is indicated in paediatric patients (3 months to 17 years of age) and in adults for the treatment of the following infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required (see sections 4. 4 ja 5. 1):- intra-abdominal infections- community acquired pneumonia- acute gynaecological infections- diabetic foot infections of the skin and soft tissue (see section 4. 4)preventionertapenem sun is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery (see section 4. on otettava huomioon viralliset ohjeet antibioottien tarkoituksenmukaisesta käytöstä.

האיחוד האירופי - פינית - EMA (European Medicines Agency)

lipomed gmbh - talidomidin - multiple myeloma - immunosuppressantit - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.

האיחוד האירופי - פינית - EMA (European Medicines Agency)

proveca pharma limited - enalapril (maleate) - sydämen vajaatoiminta - reniini-angiotensiinijärjestelmään vaikuttavat aineet - treatment of heart failure.